GMO reviews how 2022 rewarded patience as speculative assets deflated and unfashionable exposures held up. Valuation resets improved forward return prospects, while U.S. large caps and government bonds still looked expensive.
Quarterly Letter 4Q 2022
GMO
Ben Inker
Research
9 Pages
Key Takeaways
Value leadership: Defensive and value exposures held up as speculative growth faded.
Return reset: Cheaper starting points improved expected long term outcomes across many assets.
Portfolio shifts: Allocation tilted toward equities and credit while maintaining diversification.